Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Electromed, Inc. (ELMD)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
10.550.00 (0.00%)
At close: 04:00PM EDT
10.36 -0.19 (-1.80%)
After hours: 05:21PM EDT
Advertisement

Electromed, Inc.

500 Sixth Avenue NW
New Prague, MN 56071
United States
952 758 9299
https://smartvest.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees132

Key Executives

NameTitlePayExercisedYear Born
Ms. Kathleen S. SkarvanCEO, Pres & Director701.64kN/A1956
Mr. Michael Joseph MacCourtExec. Officer421.75kN/A1978
Ms. Michelle C. WirtzInterim CFO, Treasurer, Sec. & Corp. ControllerN/AN/A1983
Ms. Diane M. KaufmanVP of HRN/AN/AN/A
Mr. Christopher HollandChief Commercial OfficerN/AN/AN/A
Mr. William J. GeorgeSec.N/AN/A1949
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Corporate Governance

Electromed, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement